Assessing Allogenic Chondroprogenitor Manufacture Under Good Manufacturing Practice (GMP) Serum Free And Xeno-Free Conditions

Perry, J; Hulme, Charlotte; Rix, L; Mccarthy, Helen; Lan, T; Roberts, S; Snow, Martyn; Wright, Karina

doi:10.1016/j.joca.2023.01.223

All Outputs (4)

Clinical and Cellular Predictors of Outcomes in Autologous Conditioned Plasma Therapy for Knee Osteoarthritis: A Prospective Cohort Study (2025)
Journal Article
Selim, A., Lan, T., Hulme, C., Williams, M., Perry, J., Gallacher, P., Jermin, P., & Wright, K. (2025). Clinical and Cellular Predictors of Outcomes in Autologous Conditioned Plasma Therapy for Knee Osteoarthritis: A Prospective Cohort Study. Cartilage, https://doi.org/10.1177/19476035251323376

Introduction Autologous conditioned plasma (ACP) is a single-spin, leukocyte-poor platelet-rich plasma (PRP) that provides a plasma with a platelet concentration 2 to 3 times the blood platelet concentration. The objective of this study was to invest... Read More about Clinical and Cellular Predictors of Outcomes in Autologous Conditioned Plasma Therapy for Knee Osteoarthritis: A Prospective Cohort Study.

Characterisation of Bone Marrow Aspirate Concentrate with Thrombin Used for Repairing Osteochondral Lesions of the Talus (2025)
Journal Article
Lan, T., Wright, K. T., Makwana, N., Bing, A., Hulme, C. H., & McCarthy, H. S. (2025). Characterisation of Bone Marrow Aspirate Concentrate with Thrombin Used for Repairing Osteochondral Lesions of the Talus. The Journal of Cartilage & Joint Preservation, Article 100237. https://doi.org/10.1016/j.jcjp.2025.100237

361 ADDITION OF THROMBIN TO BONE MARROW CONCENTRATE DURING THE TREATMENT OF ANKLE CARTILAGE DEFECTS SIGNIFICANTLY INCREASES THE CONCENTRATION OF INTERLEUKIN-1 RECEPTOR ALPHA AND PLATELET-DERIVED GROWTH FACTOR BB (2024)
Presentation / Conference
Lan, T., Wright, K. T., Makwana, N., Bing, A., McCarthy, H. S., & Hulme, C. H. (2024, April). 361 ADDITION OF THROMBIN TO BONE MARROW CONCENTRATE DURING THE TREATMENT OF ANKLE CARTILAGE DEFECTS SIGNIFICANTLY INCREASES THE CONCENTRATION OF INTERLEUKIN-1 RECEPTOR ALPHA AND PLATELET-DERIVED GROWTH FACTOR BB. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria

Assessing Allogenic Chondroprogenitor Manufacture Under Good Manufacturing Practice (GMP) Serum Free And Xeno-Free Conditions (2023)
Presentation / Conference Contribution
Perry, J., Hulme, C., Rix, L., Mccarthy, H., Lan, T., Roberts, S., Snow, M., & Wright, K. (2023, March). Assessing Allogenic Chondroprogenitor Manufacture Under Good Manufacturing Practice (GMP) Serum Free And Xeno-Free Conditions. Poster presented at 2023 OARSI World Congress on Osteoarthritis, Denver, Colorado